Article Abstract
Determining and Achieving Therapeutic Targets in Attention-Deficit/Hyperactivity Disorder. [CME]
Joseph Biederman, M.D., opened the symposium by reviewing the history of attention-deficit/hyperactivity disorder (ADHD), neurologic impairment in individuals with ADHD, and the prevalence of the disorder and comorbid conditions. Dr. Biederman also explained how, together, symptoms and comorbid conditions result in the impairments associated with ADHD.
Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
Buy PDF for $40.00
Please sign in or purchase this PDF for $40.00.
Save
Share
Cite
